Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Young Century Micro-Tech (Beijing) Co., Ltd. is a biotechnology company specializing in the development of advanced microfluidic platforms for life science research and clinical diagnostics. Founded in 2015, the company focuses on high-throughput single-cell analysis, digital PCR, and liquid biopsy solutions to support precision medicine initiatives. Their core technology utilizes droplet microfluidics to partition biological samples into millions of nanoliter-sized droplets, enabling highly sensitive detection of rare biomarkers and single-cell genomic profiling. Young Century Micro-Tech provides a comprehensive suite of products, including automated instruments, specialized microfluidic chips, and optimized reagent kits. These solutions are primarily applied in oncology for monitoring minimal residual disease, as well as in reproductive health and infectious disease diagnostics. The company aims to provide robust, scalable tools that transition complex microfluidic workflows from the laboratory to the clinical setting.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Young Century Micro Tech.